Literature DB >> 21131063

Day case tonsillectomy for the treatment of obstructive sleep apnoea syndrome in children: Alder Hey experience.

Amir Saam Youshani1, Ligy Thomas, Ravi K Sharma.   

Abstract

BACKGROUND: The aim of this study was to assess the safety of paediatric adeno-tonsillectomy for obstructive sleep apnoea syndrome (OSAS) performed as a day case procedure.
METHODOLOGY: Postoperative airway related complications were prospectively evaluated in children undergoing adeno-tonsillectomy for OSAS over a 12-month period in a tertiary care centre. All data was analysed and descriptive statistics performed.
RESULTS: The overall incidence of postoperative airway related complications were 21 (10.4%) in 202 consecutively operated children. Eleven were in children with other medical co-morbidities (n=37) of which 8 occurred after 6h. Amongst those without any medical illnesses (n=165), two (1.2%) developed OSAS related complication after 6h of surgery only one of which needed medical/nursing intervention. The incidence of postoperative desaturations after 6h was 21.6% in those with co-morbidities.
CONCLUSION: It is safe to perform day case adeno-tonsillectomy for OSAS in children without any medical co-morbidities while those with other medical illnesses should be planned as in-patient procedures. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21131063     DOI: 10.1016/j.ijporl.2010.10.036

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

Review 1.  Day case adenotonsillectomy for paediatric obstructive sleep apnoea: a review of the evidence.

Authors:  Giridharan Wijayasingam; Peter Deutsch; Mudith Jindal
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-30       Impact factor: 2.503

2.  Postoperative respiratory complications in children with obstructive sleep apnoea syndrome.

Authors:  Pálma Benedek; Fanni Keserü; Gabriella Kiss; Zsolt Bella; László Rovó; Gábor Katona; András Bikov; Balázs Csoma; Zsófia Lázár
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.